• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Autologous Indium-oxinate-labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor-agonists.

作者信息

Mahevas Matthieu, Van Eeckhoudt Sandrine, Moulis Guillaume, Limal Nicolas, Languille Laetitia, Bierling Philippe, Dossier Antoine, Duriez Frédéric, Galicier Lionel, Morin Anne-Sophie, Tamburini Jérôme, Chaoui Driss, Bouscary Didier, Jijakli Ahmad A L, Khellaf Mehdi, Vaida Ioana, Michel Marc, Vercellino Laetitia, Jaddi Hind, Yollant Armelle, Dosquet Christine, Godeau Bertrand, Chomienne Christine

机构信息

Internal Medicine, French Referral Centre for Adult Immune Cytopenia, Henri Mondor University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Université Paris-Est-Créteil (UPEC University), Créteil, France.

Department of Internal Medicine, Toulouse University Hospital, Toulouse, France.

出版信息

Br J Haematol. 2019 Aug;186(3):e44-e47. doi: 10.1111/bjh.15890. Epub 2019 Apr 4.

DOI:10.1111/bjh.15890
PMID:30950041
Abstract
摘要

相似文献

1
Autologous Indium-oxinate-labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor-agonists.血小板生成素受体激动剂治疗的免疫性血小板减少症患者的自体氧肟酸铟标记血小板潴留研究
Br J Haematol. 2019 Aug;186(3):e44-e47. doi: 10.1111/bjh.15890. Epub 2019 Apr 4.
2
[Initial 111In-platelet kinetics: indicator of platelet sequestration/destruction site or quality control of platelet labelling?].[初始¹¹¹铟标记血小板动力学：血小板滞留/破坏部位的指标还是血小板标记的质量控制？]
Glas Srp Akad Nauka Med. 2005(48):101-18.
3
Determining the lifespan of platelets labelled with 111In oxinate--first results.确定用111铟草酸盐标记的血小板的寿命——初步结果。
Med Pregl. 1993;46 Suppl 1:97-9.
4
The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.二线治疗在激素抵抗性免疫性血小板减少症中的选择：单中心长期研究中血小板动力学的作用。
Am J Hematol. 2014 Nov;89(11):1047-50. doi: 10.1002/ajh.23823. Epub 2014 Aug 27.
5
Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia.促血小板生成素受体激动剂在持续性或慢性免疫性血小板减少症患者中的应用。
Eur J Haematol. 2018 Mar;100(3):304-307. doi: 10.1111/ejh.13014. Epub 2018 Jan 15.
6
[Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].[慢性免疫性血小板减少性紫癜脾切除术疗效的预测]
Glas Srp Akad Nauka Med. 2005(48):119-35.
7
The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.免疫性血小板减少症的病理生理学再探讨：血小板生成无效及血小板生成素受体激动剂在慢性免疫性血小板减少性紫癜治疗中的新作用。
Hematology Am Soc Hematol Educ Program. 2008:219-26. doi: 10.1182/asheducation-2008.1.219.
8
The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy.血小板减少性紫癜中血小板破坏的部位作为脾切除术疗效的预测指标。
Br J Haematol. 1991 Oct;79(2):271-6. doi: 10.1111/j.1365-2141.1991.tb04532.x.
9
Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia.血小板生成素受体激动剂对免疫性血小板减少症患者凝血状态的影响。
Thromb Haemost. 2014 Jul 3;112(1):65-72. doi: 10.1160/TH13-10-0873. Epub 2014 Feb 6.
10
Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.促血小板生成素受体激动剂在血液系统疾病中的应用：丹麦经验。
Platelets. 2012;23(6):423-9. doi: 10.3109/09537104.2011.634931. Epub 2011 Dec 20.

引用本文的文献

1
Homologous In-Radiolabeled Platelet Survival and Sequestration Exploration for Refractory Immunologic Thrombocytopenic purpura in Children: A Strategy to Avoid Unnecessary Splenectomy.儿童难治性免疫性血小板减少性紫癜的同源放射性标记血小板存活与滞留探索：一种避免不必要脾切除术的策略
Mol Imaging. 2024 Nov 6;23:15353508241293961. doi: 10.1177/15353508241293961. eCollection 2024 Jan-Dec.
2
Course of immune thrombocytopenia according to the site of platelet destruction identified by indium-111 platelet scintigraphy.根据铟-111血小板闪烁显像确定的血小板破坏部位的免疫性血小板减少症病程
Br J Haematol. 2025 Jan;206(1):279-289. doi: 10.1111/bjh.19833. Epub 2024 Oct 15.
3
Phenotyping of Macrophages After Radiolabeling and Safety of Intra-arterial Transplantation Assessed by SPECT/CT and MRI.
经放射性标记后巨噬细胞表型分析及 SPECT/CT 和 MRI 评估的动脉内移植安全性。
Cell Transplant. 2023 Jan-Dec;32:9636897231212780. doi: 10.1177/09636897231212780.
4
Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.免疫性血小板减少症与骨髓增生异常综合征和慢性粒单核细胞白血病相关的临床谱、结局和处理。
Haematologica. 2021 May 1;106(5):1414-1422. doi: 10.3324/haematol.2020.272559.
5
IVIg increases interleukin-11 levels, which in turn contribute to increased platelets, VWF and FVIII in mice and humans.IVIg 会增加白细胞介素-11 水平，而后者反过来又会导致小鼠和人类的血小板、血管性血友病因子和因子 VIII 增加。
Clin Exp Immunol. 2021 May;204(2):258-266. doi: 10.1111/cei.13580. Epub 2021 Feb 22.
6
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.更新的原发性免疫性血小板减少症的调查和管理国际共识报告。
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.